These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1386264)

  • 1. Inhibition of neutrophil chemotactic factor production in comedonal bacteria by subminimal inhibitory concentrations of erythromycin.
    Akamatsu H; Kurokawa I; Nishijima S; Asada Y
    Dermatology; 1992; 185(1):41-3. PubMed ID: 1386264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin, and minocycline on the neutrophil chemotactic factor production in Propionibacterium acnes biotypes 1-5.
    Akamatsu H; Nishijima S; Takahashi M; Ushijima T; Asada Y
    J Dermatol; 1991 May; 18(5):247-51. PubMed ID: 1834712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of subminimal inhibitory concentrations of minocycline on neutrophil chemotactic factor production in comedonal bacteria, neutrophil phagocytosis and oxygen metabolism.
    Akamatsu H; Niwa Y; Kurokawa I; Masuda R; Nishijima S; Asada Y
    Arch Dermatol Res; 1991; 283(8):524-8. PubMed ID: 1838472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycin.
    Webster GF; Leyden JJ; McGinley KJ; McArthur WP
    Antimicrob Agents Chemother; 1982 May; 21(5):770-2. PubMed ID: 7049078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Roxithromycin on the production of lipase and neutrophil chemotactic factor by Propionibacterium acnes.
    Akamatsu H; Tomita T; Horio T
    Dermatology; 2002; 204(4):277-80. PubMed ID: 12077521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
    J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils.
    Jain A; Sangal L; Basal E; Kaushal GP; Agarwal SK
    Dermatol Online J; 2002 Oct; 8(2):2. PubMed ID: 12546757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
    Gloor M; Wasik B; Becker A; Höffler U
    Dermatology; 2002; 205(3):260-4. PubMed ID: 12399674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
    Kurokawa I; Nishijima S; Kawabata S
    Eur J Dermatol; 1999; 9(1):25-8. PubMed ID: 9920982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro activity of 6 antimicrobials against propionibacteria isolates from untreated acne papulopustulosa.
    Fluhr JW; Gloor M; Dietz P; Höffler U
    Zentralbl Bakteriol; 1999 Feb; 289(1):53-61. PubMed ID: 10096167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
    Nishijima S; Kurokawa I; Katoh N; Watanabe K
    J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.
    Ross JI; Snelling AM; Eady EA; Cove JH; Cunliffe WJ; Leyden JJ; Collignon P; Dréno B; Reynaud A; Fluhr J; Oshima S
    Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne.
    Gübelin W; Martínez MA; Molina MT; Zapata S; Valenzuela ME
    Rev Latinoam Microbiol; 2006; 48(1):14-6. PubMed ID: 17357569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of propionibacteria to antibiotics used in the treatment of acne.
    Brown JM; Poston SM
    J Med Microbiol; 1983 Aug; 16(3):271-80. PubMed ID: 6224016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne.
    Nishijima S; Akamatsu H; Akamatsu M; Kurokawa I; Asada Y
    J Dermatol; 1994 Mar; 21(3):166-71. PubMed ID: 8014270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial resistance in French acne patients.
    Dumont-Wallon G; Moyse D; Blouin E; Dréno B
    Int J Dermatol; 2010 Mar; 49(3):283-8. PubMed ID: 20465665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotaxin production by comedonal bacteria (Propionibacterium acnes, Propionibacterium granulosum and Staphylococcus epidermidis).
    Puhvel SM; Sakamoto M
    J Invest Dermatol; 1980 Jan; 74(1):36-9. PubMed ID: 6444322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents.
    Nishijima S; Kurokawa I; Kawabata S
    J Int Med Res; 1996; 24(6):473-7. PubMed ID: 8959531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acne and Propionibacterium acnes.
    Bojar RA; Holland KT
    Clin Dermatol; 2004; 22(5):375-9. PubMed ID: 15556721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.